Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mainz Biomed N.V. - Ordinary Shares
(NQ:
MYNZ
)
0.6600
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mainz Biomed N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher
November 13, 2023
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Fall; Tyson Foods Posts Upbeat Earnings
November 13, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening Test
November 13, 2023
The integration of Artificial Intelligence (AI) in biotechnology is rapidly gaining momentum, revolutionizing the field of life sciences. AI technologies, such as machine learning and deep learning...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mainz Biomed’s (NASDAQ: MYNZ) ColoFuture Study Reveals “Groundbreaking Results”: ColoAlert® Raises The Bar For Colorectal Cancer Detection
November 08, 2023
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
What 5 Analyst Ratings Have To Say About Mainz Biomed
September 26, 2023
Via
Benzinga
AI Meets Oncology! Mainz Biomed Inks Pact With Liquid Biosciences To Develop Next-Gen Colorectal Cancer Screening Test
November 07, 2023
Mainz Biomed N.V. (NASDAQ: MYNZ) inked a pact with Liquid Biosciences, a bio-analytics company leveraging its proprietary AI analysis technology platform (EMERGE), to enhance the
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test
November 07, 2023
On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report.
Via
Benzinga
Exposures
COVID-19
Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection
November 07, 2023
Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer.
Via
Benzinga
Splunk Layoffs 2023: What to Know About the Latest SPLK Job Cuts
November 01, 2023
Splunk layoffs are on the way for 7% of the cybersecurity company's global employees as it continues a restructuring plan.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is WeWork (WE) Stock Down 38% Today?
November 01, 2023
WeWork stock is falling on Wednesday as investors in WE shares react to reports that the company is considering a bankruptcy filing.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Why Is Paycom Software (PAYC) Stock Down 39% Today?
November 01, 2023
Paycom Software stock is falling hard on Wednesday as investors in PAYC go over the company's mixed earnings report for Q3 2023!
Via
InvestorPlace
Why Is Mainz Biomed (MYNZ) Stock Moving Today?
November 01, 2023
Mainz Biomed stock is on the move Wednesday as investors in MYNZ react to results from a colorectal cancer screening test campaign.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 01, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!
Via
InvestorPlace
Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results
October 31, 2023
As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter.
Via
Benzinga
Exposures
COVID-19
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
October 17, 2023
Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...
Via
Benzinga
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
October 04, 2023
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated.
Via
Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in...
Via
Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 13, 2023
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...
Via
Benzinga
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
September 13, 2023
By the words of Dr. Ruediger Dahlke, cancer is a caricature of today’s modern society as it reflects the dark side ‘growth’. Our civilization is clearly more on the dark side of growth with technology...
Via
Benzinga
Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
September 13, 2023
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
September 06, 2023
--News Direct--
Via
News Direct
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...
Via
Benzinga
Exposures
COVID-19
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
September 05, 2023
The WHO reports that colorectal cancer is the second most fatal cancer around the world.
Via
Benzinga
Second Most Fatal Cancer In U.S. May Face A Big Fight From Mainz Biomed’s Non-Invasive Test; (NASDAQ: MYNZ) Is Making Early Detection Possible
August 30, 2023
--News Direct--
Via
News Direct
Second Most Fatal Cancer In U.S. May Soon Face A Challenger: Mainz Biomed's (NASDAQ: MYNZ) Early Detection Tech
August 29, 2023
Colorectal cancer is the third most common cancer worldwide, and although the majority of colorectal cancer cases have historically occurred in individuals aged 45 and older, it is increasingly...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.